Skip to content

A study to verify the effects of nomimamori gummy on promoting alcohol metabolism and removing acetaldehyde: an open-label study

A study to verify the effects of nomimamori gummy on promoting alcohol metabolism and removing acetaldehyde: an open-label study - A study to verify the effects of nomimamori gummy on promoting alcohol metabolism and removing acetaldehyde

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060774
Enrollment
15
Registered
2026-02-27
Start date
2026-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Duration: Single ingestion Interval period: two weeks Test product: nomimamori gummy Administration: Test 1: Each measurement is performed after drinking 100 mL per 60 kg body weight of 25% shochu

Sponsors

National university corporation Tokushima University
Lead Sponsor
Okuno chemical industries Co.,Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Individuals aged between 20 and 50 4. Healthy individuals 5. Individuals who show moderate activity in alcohol-metabolizing gene test (Genemetry)

Exclusion criteria

Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, stroke disorder, dyslipidemia, hypertension, neoplastic disease, hemorrhagic disease, infectious disease, or any other chronic diseases 4. Individuals who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional foods/beverages on a daily basis 5. Individuals who are currently taking medications (including herbal medicines) and supplements 6. Individuals who are allergic to medicines and foods related to the test food (particularly alcohol) 7. Individuals who are pregnant, lactating, or planning to become pregnant during this study 8. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 9. Individuals who are smokers 10. Individuals who plan to drive a car or ride a bicycle after the examinations on the test day 11. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. Blood test (ethanol, acetaldehyde, and aldehyde dehydrogenase)

Secondary

MeasureTime frame
1. Questionnaires 2. Doctor's view

Countries

Japan

Contacts

Public ContactKenta Suzuki

Okuno chemical industries Co.,Ltd. Research, Food

k-suzuki01@okuno.co.jp06-6961-5437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026